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The side population (SP), which overexpresses ABC-family membrane transport-
ers including ABCG2 (also referred to as Breast Cancer Resistance Protein or BRCP), 
is thought to be enriched in cancer stem cells (CSC). SP cells are characterized by the 
capacity of extruding the Hoechst 33342 dye. The difficulty in eradicating tumors might 
be due to the fact that conventional treatments target the bulk of the tumor cells leaving 
behind the CSCs. Since CSCs may be responsible for aggressive behaviour of certain tu-
mors as well as their sustained growth, strategies that target these cells will have signifi-
cant clinical implications. So far the SP of T-cell acute lymphoblastic leukemia (T-ALL) 
has not been identified. Here, we have investigated the possible existence of SP cells in 
T-ALL cell lines and patients. In addition, we have studied if SP cells were sensitive to 
modulators of the PI3K/Akt/mTOR pathway. SP cells were analyzed using a Cell Lab 
Quanta SC flow cytometer equipped with an UV lamp and a 488 solid state laser. The 
Hoechst 33342 dye was excited at 366 nm. SP cells were gated on the FL1/FL3 histogram, 
while ABCG2 staining was evaluated on the FL2 channel. Hoechst staining specificity 
was demonstrated by the use of ABC-family transporter blocking agents (verapamil, 
fumitremorgin C, Ko143). The analysis documented the existence of cells displaying SP 
features (2.7-7.5%). Flow cytometric analysis demonstrated that the T-ALL SP expresses 
high levels of ABCG2, whereas the expression of two other ABC-family member trans-
porters, P-gp or MRP1, was not detected. SP cells disappeared in samples treated with 
BEZ-235 (a dual inhibitor of PI3K/mTOR) or rapamycin (an mTORC1 inhibitor). Our 
findings indicate that SP cells exist also in T-ALL and are sensitive to PI3K/Akt/mTOR 
inhibition. Taken together, our preclinical findings strongly suggest that modulators of 
PI3K/AKT/mTOR could be valuable compounds for treating T-ALL because of their 
capability of targeting a population enriched in CSCs.
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